Approximately 10–15% of ovarian cancer is due to germline mutations in BRCA1 or BRCA2 (collectively termed “BRCA”), rising to 15–20% of non-mucinous ovarian cancer2, 3, 4, 5, 6. Here, BRCA2 is linked to ovarian cancer.